Author

Fabienne Flühmann

Paul Scherrer Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Ana Katrina MapanaoiD· 1 shared Cristina MülleriD· 1 shared Jan Rijn ZeevaartiD· 1 shared Julia Fricke· 1 shared Kristel KegleriD· 1 shared Nicholas P. van der MeuleniD· 1 shared Peter BernhardtiD· 1 shared Roger SchibliiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ana Katrina MapanaoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Comparison of the tolerability of 161Tb- and 177Lu-labeled somatostatin analogues in the preclinical setting

Sarah D. Busslinger, Ana Katrina Mapanao, Kristel Kegler, Peter Bernhardt, Fabienne Flühmann, Julia Fricke, Jan Rijn Zeevaart, U. Köster, Nicholas P. van der Meulen, Roger Schibli, Cristina Müller

This study compares the tolerability of 161Tb- and 177Lu-labeled somatostatin analogues in mice, finding that SSTR antagonists caused more hematologic changes than agonists, but both were safe at therapeutic activity levels.

European Journal of Nuclear Medicine and Molecular Imaging · Jul 24, 2024Peer-reviewedCancer Biology